| Literature DB >> 30122007 |
J J Hu1, M J Zheng1, Y Chen2, L Y Yu1, H Yang1.
Abstract
The treatment for laryngopharyngeal reflux diseases consist of general treatment, medical therapy and surgical treatment, among which, drug therapy is still the main effective way. Proton pump inhibitor is adopted as the first drug for patients with laryngopharyngeal reflux disease only caused by acid reflux. With standardized treatment, the majority of symptoms in laryngopharyngeal reflux disease could be alleviated effectively. PPI therapy, while seeming logical, is less useful in patients with reflux hypersensitivity, weak acid or non acid reflux, neuropsychic factors and gastroesophageal reflux disease. This article aims to investigate bewilderment and challenge faced by clinicians when managing adult laryngology reflux disease with medical therapy.Entities:
Keywords: Drug therapy; Laryngopharyngeal reflux
Mesh:
Substances:
Year: 2018 PMID: 30122007 DOI: 10.3760/cma.j.issn.1673-0860.2018.08.017
Source DB: PubMed Journal: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi ISSN: 1673-0860